Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert


Search Title by author or title

Anterior chamber foldable phakic IOL: safety and efficacy

Poster Details

First Author: A. Hasan EGYPT

Co Author(s):                        

Abstract Details


To assess the visual outcome stability and safety of eyes undergoing Anterior chamber foldable phakic lens implantation(Artiflex) (Ophtec BV, Groningen, The Netherlands) or ( veriflex) (AMO,Santa Ana,CA) for myopia unsuitable for LASIK and detection of early and late complications along three years follow up period.


Sohag Faculty of Medicine, Egypt


Retrospective analysis of 25 eyes of 16 patients underwent Anterior chamber foldable phakic IOL(Artiflex) or ( Veriflex) implantation for correction of myopia all patients were unsuitable for LASIK all patients underwent surgery with one surgeon in same circumstances. Uncorrected visual acuity, corrected visual acuity, higher-order aberrations, patient satisfaction, central endothelial cell count, and PIOL position centration and incarcerated iris tissue were determined along follow up period.


A total of 25 eyes from 16 patients were reviewed. Follow-up for 36. At final follow-up, 14 of the 25 eyes (56 %) achieved best-corrected visual acuity (BCVA) better than that measured pre-operatively and 10 of the 25 eyes (40%) matched their pre-operative BCVA. 1 eyes, (4 %) attained a final BCVA worse than pre-operatively, one due to recurrent uveitis only one patient (4%) need another surgery to refixate the lens due to slippage of incarcerated iris tissue with impending displacement.


This study suggests that Anterior chamber foldable phakic IOL (iris claw lens insertion) Ariflexor Veriflex is beneficial in myopia , unsuitable for LASIK , matching or exceeding pre-operative BCVA in the overwhelming majority of the cases. With no major complications however long standing follow up is needed to avoid major complications.

Financial Disclosure:


Back to Poster listing